e-learning
resources
Milan 2017
Monday, 11.09.2017
Late-breaking findings in pulmonary diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Responder phenotyping using functional respiratory imaging (FRI) in IPF patients treated with anti-CGTG monoclonal antibody FG3019
E. Kouchakji (San Francisco, United States of America), M. Lanclus
Source:
International Congress 2017 – Late-breaking findings in pulmonary diseases
Session:
Late-breaking findings in pulmonary diseases
Session type:
Thematic Poster
Number:
2811
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Kouchakji (San Francisco, United States of America), M. Lanclus. Late Breaking Abstract - Responder phenotyping using functional respiratory imaging (FRI) in IPF patients treated with anti-CGTG monoclonal antibody FG3019. 2811
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Late Breaking Abstract - Characterizing responders to benralizumab for severe asthma: pooled analysis of the SIROCCO and CALIMA studies
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017
Late Breaking Abstract - Prevalence and clinical significance of antinuclear antibody (ANA) in IPF: analysis from ESTAIR study
Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias
Year: 2018
Late Breaking Abstract - Identification of patients with COPD who benefit from benralizumab
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019
Late Breaking Abstract - Assessment of disease progression in IPF patients using Functional Respiratory Imaging (FRI)
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017
Late Breaking Abstract - The biological pathways underlying response to anti-IL-17A (AIN457; secukinumab) therapy differ across severe asthmatic patients.
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017
Late Breaking Abstract - Change in airway volume, measured with functional respiratory imaging (FRI), differentiates between stable and progressive idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Late Breaking Abstract - Functional respiratory imaging (FRI) and lung function assessment of glycopyrronium/formoterol fumarate dihydrate fixed-dose combination delivered using novel Co-Suspension Delivery Technology (GFF MDI) in COPD
Source: International Congress 2017 – Novel studies on bronchodilators and cough
Year: 2017
Late Breaking Abstract - Early benefits in patient-reported outcomes (PROs) and physical activity (PA) in patients with severe eosinophilic asthma (SEA) treated with benralizumab: interim analysis of the imPROve Asthma study
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Late Breaking Abstract - Compare outcomes between COPD patients treated with Tiotropium/Olodaterol (TIO/OLO) and other fixed-dose LAMA/LABAs
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
Late Breaking Abstract - Tocilizumab (T) plus pembrolizumab (P) in patients (pts) with Covid-19 pneumonia: COPERNICO
Source: Virtual Congress 2021 – COVID-19 acute respiratory distress syndrome
Year: 2021
Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Late Breaking Abstract: Novel detection of exacerbations of COPD with patient reported outcome (EXACT-PRO) and Blackberry (BB)
Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring
Year: 2010
Late Breaking Abstract - ENose based phenotyping of newly presented patients with asthma or COPD
Source: International Congress 2018 – Biomarkers in COPD and asthma
Year: 2018
Change of T2-markers in patients with severe uncontrolled asthma treated by monoclonal antibodies: 1 yr follow up
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021
Late Breaking Abstract - Comparison of clinical characteristics between severe adult asthmatics in Brazil(ProAR) and Europe(U-BIOPRED).
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017
Late Breaking Abstract - Compare outcomes between COPD patients treated with tiotropium/olodaterol (TIO/OLO) and umeclidium/vilanterol (UMEC/VI)
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Late Breaking Abstract - Lung deposition of two different ICS/LABA combinations with Dry Powder Inhaler (DPI) in asthmatic patients using Functional Respiratory Imaging (FRI).
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Year: 2019
Late Breaking Abstract - Clinical utility of basophil activating test (BAT) in subjects with drug-induced lung disease.
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management
Year: 2018
Long-term treatment with monoclonal antibodies anti-IgE in severe asthma: Follow-up of ten patients
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept